Conclusion
Our study sheds light on the possible mechanisms through which thalidomide and lenalidomide might be effective in the management of SARS-coV-2 pathology. Thalidomide and derivatives effectively modulating various aberrantly regulated pathways infections with abundant pharmacological information available make them promising candidates for the treatment of novel coronavirus infections.